Cardinal Health Total Depreciation and Amortization - Cash Flow 2010-2025 | CAH
Cardinal Health annual/quarterly total depreciation and amortization - cash flow history and growth rate from 2010 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
- Cardinal Health total depreciation and amortization - cash flow for the quarter ending March 31, 2025 was $581M, a 10.88% increase year-over-year.
- Cardinal Health total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $1.847B, a 6.46% increase year-over-year.
- Cardinal Health annual total depreciation and amortization - cash flow for 2024 was $0.71B, a 2.6% increase from 2023.
- Cardinal Health annual total depreciation and amortization - cash flow for 2023 was $0.692B, a 0% decline from 2022.
- Cardinal Health annual total depreciation and amortization - cash flow for 2022 was $0.692B, a 11.62% decline from 2021.
Cardinal Health Annual Total Depreciation and Amortization - Cash Flow
(Millions of US $) |
| 2024 |
$710 |
| 2023 |
$692 |
| 2022 |
$692 |
| 2021 |
$783 |
| 2020 |
$913 |
| 2019 |
$1,000 |
| 2018 |
$1,032 |
| 2017 |
$717 |
| 2016 |
$641 |
| 2015 |
$451 |
| 2014 |
$459 |
| 2013 |
$397 |
| 2012 |
$325 |
| 2011 |
$313 |
| 2010 |
$254 |
| 2009 |
$226 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$36.816B |
$226.827B |
|
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
|
